Granzyme B PET/CT Imaging Evaluates Early Response to Immunotherapy in Gastric Cancer

免疫疗法 颗粒酶B 癌症 医学 颗粒酶 癌症免疫疗法 癌症研究 肿瘤科 内科学 免疫系统 免疫学 穿孔素 T细胞 CD8型
作者
Qiufang Liu,Xiaoping Xu,Ziyi Yang,Jianping Zhang,Jindian Li,Ying Qiao,Silong Hu,Xiaosheng Liu,Weijian Guo,Shaoli Song
出处
期刊:Journal of nuclear medicine [Society of Nuclear Medicine and Molecular Imaging]
卷期号:65 (11): 1695-1701 被引量:19
标识
DOI:10.2967/jnumed.124.267529
摘要

In several malignancies, only a limited number of patients respond to immune checkpoint inhibitors. Predicting and monitoring responses to these inhibitors represent an unmet clinical need. Here, we developed a PET/CT probe targeting granzyme B, [68Ga]Ga-NOTA-Gly-Gly-Gly-Ile-Glu-Pro-Asp-CHO (GSI), and aimed to investigate whether it can be used to monitor the effects of immune checkpoint inhibitors early in the course of therapy. Methods: Seventy-two patients with gastric cancer (stages III–IV) were recruited for [68Ga]Ga-DOTA-GSI PET/CT imaging after 2 or 3 cycles of the immunotherapy, and 40 patients were included in the final analysis. The SUVmax of primary tumors (SUVmax-t), SUVmax of metastatic lymph nodes (SUVmax-LN), and SUVmax of normal tissues (liver and blood pool) were measured, and their target-to-liver background ratio (TLR) and target-to-blood background ratio (TBR) were denoted for primary tumors as TLRtumor and TBRtumor and for metastatic lymph nodes as TLRLN and TBRLN, respectively. The treatment responses were assessed within 1 wk after full-course treatment according to RECIST version 1.1. Wilcoxon rank-sum tests were used to compare the PET/CT parameters between responders and nonresponders. Receiver operating characteristic curve analysis was used to assess the diagnostic efficacy of [68Ga]Ga-DOTA-GSI PET/CT parameters in identifying responders. Two-tailed P value of less than 0.05 was considered statistically significant. Results: We found that SUVmax-t, TLRtumor, TBRtumor, SUVmax-LN, and TBRLN were higher in responders than in nonresponders (2.49 ± 0.58 vs. 1.55 ± 0.48, P = 0.000; 2.24 ± 0.48 vs. 1.74 ± 0.67, P = 0.007; 1.38 ± 0.43 vs. 0.90 ± 0.23, P = 0.000; 2.24 ± 0.99 vs. 1.42 ± 0.55, P = 0.003; and 1.28 ± 0.68 vs. 0.83 ± 0.32, P = 0.012, respectively). According to receiver operating characteristic curve analysis, the area under the curve for SUVmax-t, TBRtumor, TLRtumor, SUVmax-LN, TLRLN, and TBRLN was 0.886, 0.866, 0.746, 0.772, 0.648, and 0.731, respectively. The threshold of SUVmax-t was 2.05, and its sensitivity and specificity were 81.0% and 84.2%, respectively. In addition, multivariate logistic regression indicated that TBRtumor was an independent predictor of treatment response (P = 0.03). Conclusion: Our results indicated that [68Ga]Ga-DOTA-GSI PET/CT is a promising tool for predicting early response to combined immunotherapy in gastric cancer patients.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
1秒前
大模型的应助被ow采纳,获得10
1秒前
tatata完成签到,获得积分20
2秒前
2秒前
Peter_Zhu完成签到,获得积分10
3秒前
沥练的应助被萌萌大头菜采纳,获得10
3秒前
科研进化中完成签到,获得积分10
4秒前
樱桃小狗完成签到,获得积分10
4秒前
zlyaaa发布了新的文献求助10
5秒前
luoluo完成签到,获得积分10
5秒前
丢丢完成签到,获得积分10
6秒前
WangYF2025完成签到 ,获得积分10
6秒前
6秒前
yyyyy_完成签到 ,获得积分10
7秒前
gytu关注了科研通微信公众号
7秒前
zsy完成签到,获得积分10
7秒前
悦尼酱完成签到,获得积分10
7秒前
俭朴舞仙完成签到 ,获得积分10
7秒前
未了发布了新的文献求助10
7秒前
天真酸奶发布了新的文献求助10
7秒前
香蕉黑米完成签到,获得积分10
8秒前
ace完成签到,获得积分10
8秒前
9秒前
9秒前
青桔子完成签到,获得积分10
9秒前
迷人大凄发布了新的文献求助10
9秒前
Yuuu完成签到,获得积分10
9秒前
迷路鞋子的应助被Maestro_S采纳,获得10
9秒前
科研通AI6.4的应助被喜悦傲霜采纳,获得10
9秒前
9秒前
无敌幸运星完成签到,获得积分10
9秒前
annie完成签到,获得积分10
11秒前
11秒前
11秒前
大个的应助被铁锤牛马版采纳,获得10
11秒前
完美世界的应助被阿飞采纳,获得10
11秒前
搞怪的芷波给搞怪的芷波的求助进行了留言
11秒前
停騮_ 完成签到,获得积分10
12秒前
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180586
求助须知:如何正确求助?哪些是违规求助? 9570581
关于积分的说明 21813457
捐赠科研通 7776777
什么是DOI,文献DOI怎么找? 3433294
关于科研通互助平台的介绍 2557547
邀请新用户注册赠送积分活动 2479253